Depression icon

Vagus Nerve Stimulation as a Treatment for Depression to be Launched in May


Final FDA approval of vagus nerve stimulation as a therapy for chronic or recurrent treatment-resistant depression to be issued in May. Psychiatrists will then officially be able to prescribe this remarkable, life changing therapy for patients.

On April 7th, 2005, the manufacturer of the vagus nerve stimulator( Cyberonics, Inc.) announced that it had been notified by the U.S. Food and Drug Administration(FDA) that one the few remaining conditions of final FDA approval had been satisfied. Cyberonics also announced that it was very confident that the two remaining conditions will be expeditously satisfied and that final FDA approval will be issued in May.

Robert P. ("Skip") Cummins, Cyberonics' Chairman of the Board and Chief Executive Officer commented: "This major step forward towards the accomplishment of Cyberonics' mission to improve the lives of people touched by refractory epilepsy and treatment-resistant depression (TRD) would not have been possible without the timely, diligent, interactive and cooperative efforts of the entire Dallas District Office staff led by Michael Chappell, District Director, and the Cyberonics regulatory team. Cyberonics and CDRH continue to make good progress towards our goal of satisfying the remaining conditions of final TRD approval."

The official launch of vagus nerve stimulation as a treatment for depression will take place at the American Psychiatric Association's Annual Meeting at the World Congress Center in Atlanta from May 21st to May 25th. The Annual Meeting will be attended by over 20,000 psychiatrists.

Major depressive disorder is one of the most prevalent and serious illnesses in the U.S., affecting nearly 19 million Americans every year. Depression is the second leading cause of disability for the general population and the leading cause of disability for American women. Approximately 20 percent of depressed Americans, or approximately four million people, experience chronic or recurrent treatment-resistant depression that has failed to respond to multiple antidepressant treatments. If approved, the VNS Therapy System will be the first implantable device-based treatment for depression and the first treatment developed, studied and labeled specifically for patients with treatment-resistant depression.

Vagus nerve stimulation will be the mainstream treatment for chronic or treatment-resistant depression. Over four million American suffer from chronic depression. The final FDA approval will be considered one of the major breakthroughs in medical device history.

You can learn more at http://www.VagusNerveStimulator.com. There is a free electronic newsletter to keep you up-to-date.

Charles Donovan was a patient in the FDA investigational trial of vagus nerve stimulation as a treatment for chronic or recurrent treatment-resistant depression. He was implanted with the vagus nerve stimulator in April of 2001. He chronicles his journey from the grips of depression thanks to vagus nerve stimulation therapy in his book:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression

The book will be exhibited at the American Psychiatric Association's Annual Meeting in May.

He is editor the http://www.VagusNerveStimulator.com Web Site


MORE RESOURCES:

Health Tip: Factors That May Aggravate Acne in Women
U.S. News & World Report
(HealthDay News) -- Acne, the most common skin disease, is not a dangerous condition. But it can lead to permanent scarring. Changes in hormone levels ...
Health Tip: Factors That May Aggravate Acne in WomenNewsday (subscription)

all 3 news articles »


Acne Unveils 'Transvestite and Cross-Dressing' Collection
TIME
Acne, the Stockholm-based fashion house known for its high-end denim, has released a collection of shirts meant to merge high fashion and gender-bending. ...



New York Daily News

Acne Launches Transvestite Shirt Collection (PHOTOS)
Huffington Post (blog)
Swedish label Acne, in conjunction with Candy magazine, has launched a collection of three shirts aimed specifically at cross-dressers and transvestites, ...
He/She's got the look: Swedish clothing line ACNE launches shirts aimed at ...New York Daily News
Acne launches range for transvestitesThe Vine
Acne launches a new transexual collectionwallpaper.com
Gawker (blog) -The Local.se
all 6 news articles »


Fashion Week Staff Picks
New York Times
And the DJ Jacques Renault will be at the Acne party at Fashion's Night Out to satiate my second guiltiest pleasure (after Popeye's): disco.” Friday, Sept. ...



Medicis Announces New Patent for SOLODYN(R)
MarketWatch (press release)
The new patent, entitled "Minocycline Oral Dosage Forms for the Treatment of Acne," relates to the use of dosage forms of SOLODYN which provide ...

and more »


PR Web (press release)

New, Exclusive Strength: Tretin-X® 0.0375%(tretinoin) Cream
PR Web (press release)
New strength offers a JUST RIGHT approach for acne patients. Triax Pharmaceuticals, LLC announced today the approval of a new, topical retinoid with an ...

and more »


Fridge fixins for a fabulous face
Marist College The Circle
Spas and salons offer facials that make your skin softer, reduce acne, make pores appear smaller, get rid of blackheads and more. ...



Fashion line aims for androgyny
UPI.com
Fashion label Acne said it teamed with Candy Magazine, a publication dedicated to transvestism, transexuality, cross dressing and androgyny, ...

and more »


Seven Surprising Uses for Baking Soda
GOOD (blog)
Let us be clear: Baking soda is not going to permanently cure your acne or turn back the cruel hand of time. But if you're looking to detoxify your body and ...



The FADER (blog)

Acne Blurs the Gender Binary with a Transsexual Collection
The FADER (blog)
Leave it to Acne to shake things up a bit. In conjunction with Candy, a zine that celebrates transsexuality, they've released this gender-neutral collection ...


Google News

home | site map
© 2009